| 0 (0%) | 09-27 11:13 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.43  |
1-year : | 6.05 |
| Resists | First : | 4.65 |
Second : | 5.17 |
| Pivot price | 4.27 |
|||
| Supports | First : | 3.79 | Second : | 3.16 |
| MAs | MA(5) : | 4.07 |
MA(20) : | 4.36 |
| MA(100) : | 3.64  |
MA(250) : | 3.11 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 28 |
D(3) : | 28.7 |
| RSI | RSI(14): 43.2 |
|||
| 52-week | High : | 6.92 | Low : | 1.75 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SNOA ] has closed above bottom band by 21.5%. Bollinger Bands are 35.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.16 - 4.18 | 4.18 - 4.21 |
| Low: | 3.91 - 3.94 | 3.94 - 3.97 |
| Close: | 3.99 - 4.04 | 4.04 - 4.09 |
Fri, 26 Sep 2025
Sonoma Pharmaceuticals Enters Sales Agreement with Ladenburg - TipRanks
Thu, 25 Sep 2025
News by Acceswire on TradingView, 2025-09-25 - TradingView
Thu, 25 Sep 2025
Healthcare Tech Leader Sonoma Pharmaceuticals to Showcase Microcyn Technology at Fall Investor Conference - Stock Titan
Mon, 22 Sep 2025
Breakout Move: Will SNOA benefit from rising consumer demand - Inflation Watch & AI Enhanced Trade Execution Alerts - خودرو بانک
Thu, 18 Sep 2025
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Screens Well But There Might Be A Catch - simplywall.st
Fri, 05 Sep 2025
Add to playlist: ultra-prolific Leicester rapper Snoa plus the week’s best tracks - The Guardian
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 6.3 (%) |
| Shares Short | 85 (K) |
| Shares Short P.Month | 19 (K) |
| EPS | -2.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.47 |
| Profit Margin | -23.9 % |
| Operating Margin | -27.3 % |
| Return on Assets (ttm) | -16.1 % |
| Return on Equity (ttm) | -78.8 % |
| Qtrly Rev. Growth | 18.3 % |
| Gross Profit (p.s.) | 3.42 |
| Sales Per Share | 9.09 |
| EBITDA (p.s.) | -2.14 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -1.83 |
| PEG Ratio | 0 |
| Price to Book value | 1.63 |
| Price to Sales | 0.44 |
| Price to Cash Flow | -5.57 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|